Stay Ahead of Compliance with Monthly Citation Updates


In your State Survey window and need a snapshot of your risks?

Survey Preparedness Report

One Time Fee
$79
  • Last 12 months of citation data in one tailored report
  • Pinpoint the tags driving penalties in facilities like yours
  • Jump to regulations and pathways used by surveyors
  • Access to your report within 2 hours of purchase
  • Easily share it with your team - no registration needed
Get Your Report Now →

Monthly citation updates straight to your inbox for ongoing preparation?

Monthly Citation Reports

$18.90 per month
  • Latest citation updates delivered monthly to your email
  • Citations organized by compliance areas
  • Shared automatically with your team, by area
  • Customizable for your state(s) of interest
  • Direct links to CMS documentation relevant parts
Learn more →

Save Hours of Work with AI-Powered Plan of Correction Writer


One-Time Fee

$49 per Plan of Correction
Volume discounts available – save up to 20%
  • Quickly search for approved POC from other facilities
  • Instant access
  • Intuitive interface
  • No recurring fees
  • Save hours of work
F0605
D

Failure to Attempt Gradual Dose Reduction of Psychotropic Medication

Manchester, New Hampshire Survey Completed on 07-31-2025

Penalty

No penalty information released
tooltip icon
The penalty, as released by CMS, applies to the entire inspection this citation is part of, covering all citations and f-tags issued, not just this specific f-tag. For the complete original report, please refer to the 'Details' section.

Summary

A deficiency was identified when a resident with a diagnosis of dementia with psychotic disturbance was maintained on Risperdal (an antipsychotic) for an extended period without a documented attempt at gradual dose reduction (GDR), as required. The resident had been stable, with no acute concerns or documented psychiatric or behavioral issues, and nursing progress notes did not indicate any behaviors that would contraindicate a GDR. Despite this, the resident's Durable Power of Attorney (DPOA) consistently refused attempts at GDR, and the facility did not document any clinical contraindication for not attempting a reduction. Interviews with facility staff confirmed that no GDR had been attempted and that the resident had not exhibited psychotic or hallucinatory episodes. The facility's own policy requires consideration of medication tapering when a resident's condition is stable, and mandates GDR for residents on psychotropic medications unless clinically contraindicated. The lack of documented clinical justification for not attempting a GDR constituted a failure to comply with both facility policy and regulatory requirements.

An unhandled error has occurred. Reload 🗙